NRF2, cancer and calorie restriction
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The transcription factor NF-E2-related factor (NRF2) is a key regulator of several enzymatic pathways, including cytoprotective enzymes in highly metabolic organs. In this review, we summarize the ongoing research related to NRF2 activity in cancer development, focusing on in vivo studies using NRF2 knockout (KO) mice, which have helped in defining the crucial role of NRF2 in chemoprevention. The lower cancer protection observed in NRF2 KO mice under calorie restriction (CR) suggests that most of the beneficial effects of CR on the carcinogenesis process are likely mediated by NRF2. We propose that future interventions in cancer treatment would be carried out through the activation of NRF2 in somatic cells, which will lead to a delay or prevention of the onset of some forms of human cancers, and subsequently an extension of health- and lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · cited 4×
“The interaction between NRF2 and Keap1 has been shown by yeast two-hybrid screening (Itoh et al., 1999).”
InfluentialCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 2×
“Of note, NRF2 inhibits inflammation through decreasing expression of the pro-inflammatory mediators cyclooxygenase-2, interleukin-1b, interleukin-6 and tumour necrosis factor-a (Khor et al., 2006; Kensler et al., 2007; Hayes and McMahon, 2009).”
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947 · cited 1×
“…modify cellular molecules, resulting in lipid peroxidation, DNA strand break, telomere shortening and protein carbonylation (Dexter et al., 1989; Halliwell, 1992, 1996b; Djuric and Kritschevsky, 1993; Shaw et al., 1995; Fitzmaurice et al., 1996; Halliwell, 1996a, 2001; Alam et al., 1997a, b;…”
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · cited 4×
“NRF3 likely acts as a major regulator of phase 2 enzyme genes, as NRF3 is not expressed in most metabolic organs, such as the liver and intestine (Braun et al., 2002; Derjuga et al., 2004; Kobayashi et al., 2004b).”
InfluentialDinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 2×
“This protein is repressed in homeostatic conditions maintaining a low basal level of cytoprotective gene expression (Motohashi and Yamamoto, 2004; Motohashi et al., 2004).”
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 2×
“…of four proteins, p45-NFE2, NRF1, NRF2 and NRF3, as well as two distantly related proteins termed Bach1 and Bach2 (Chan et al., 1993a, 1993b; Moi et al., 1994; Itoh et al., 1995; Oyake et al., 1996; Muto et al., 1998; Kobayashi Received 16 July 2010; revised 8 September 2010; accepted 18…”
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502 · cited 1×
“…and protein carbonylation (Dexter et al., 1989; Halliwell, 1992, 1996b; Djuric and Kritschevsky, 1993; Shaw et al., 1995; Fitzmaurice et al., 1996; Halliwell, 1996a, 2001; Alam et al., 1997a, b; Stadtman and Berlett, 1998; Cakatay et al., 2001; Warita et al., 2001; Volchegorskii et al., 2004).”
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480 · cited 1×
“Keap1 sequesters NRF2 in the cytoplasm and acts as an adaptor enhancing the interaction of the Cullin 3-based E3-ubiquitin ligase complex 2 (Zhang and Hannink, 2003; Cullinan et al., 2004; Kobayashi et al., 2004a; McMahon et al., 2004; Furukawa and Xiong, 2005).”
McMahon, M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300931200 · Cited by 1,141 · cited 1×
“NRF2 is an unstable protein that has an estimated half-life time of 30min (McMahon et al., 2003).”
Ramos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060 · cited 1×
“This fact promotes nuclear localization of NRF2 and constitutive expression of its downstream targets, which facilitates resistance of lung tumour cells to chemotherapeutic drugs (Padmanabhan et al., 2006; Singh et al., 2006; Tong et al., 2006b; Pearson et al., 2008).”
Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M.-I., Kobayashi, A., Yamamoto, M., Kensler, T. W., & Talalay, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307301101 · Cited by 986 · cited 3×
“Once NRF2 is released from Keap1 by any of these mechanisms, NRF2 can be imported into the nucleus (Dinkova-Kostova et al., 2002; Wakabayashi et al., 2004).”
Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., & Diehl, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8477-8486.2004 · Cited by 986
Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans
Tullet, J. M. A., Hertweck, M., An, J. H., Baker, J., Hwang, J. Y., Liu, S., Oliveira, R. P., Baumeister, R., & Blackwell, T. K. (2008) · Cell · doi:10.1016/j.cell.2008.01.030 · Cited by 923 · cited 1×
“Downstream targets of SKN-1 overlap with pathways regulated by CR and lifespan promoting an increased longevity and healthspan under SKN-1 overexpression in worms (Tullet et al., 2008).”
Alam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759 · cited 4×
“The first interaction is through the ETGE, and subsequently the DLG docks onto the adjacent unoccupied Kelch-repeat domain.”
InfluentialStructural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · cited 1×
“This fact promotes nuclear localization of NRF2 and constitutive expression of its downstream targets, which facilitates resistance of lung tumour cells to chemotherapeutic drugs (Padmanabhan et al., 2006; Singh et al., 2006; Tong et al., 2006b; Pearson et al., 2008).”
Onken, B., & Driscoll, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008758 · Cited by 671 · cited 5×
“Oncogene lifespan through SKN-1 pathway in a conserved biochemical mechanism that acts like a CR mimetic (Onken and Driscoll, 2010).”
InfluentialTwo neurons mediate diet-restriction-induced longevity in C. elegans
Bishop, N. A., & Guarente, L. (2007) · Nature · doi:10.1038/nature05904 · Cited by 643
Inflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
Nguyen, T., Sherratt, P. J., Huang, H.-C., Yang, C. S., & Pickett, C. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207293200 · Cited by 615
Johnson, J. B., Summer, W., Cutler, R. G., Martin, B., Hyun, D.-H., Dixit, V. D., Pearson, M., Nassar, M., Tellejohan, R., Maudsley, S., et al. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.005 · Cited by 604 · cited 1×
“In order to develop a preventive strategy for cancer treatment in humans a periodic fasting or intermittent CR has been proposed to be attainable and beneficial (Williams et al., 1998; Johnson et al., 2007)).”
Halagappa, V. K. M., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., LaFerla, F. M., & Mattson, M. P. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.019 · Cited by 580
Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice
Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050538 · Cited by 580
Nrf2, a multi‐organ protector?
Lee, J., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J., & Johnson, J. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-2591hyp · Cited by 532
Transcriptional regulation of the rat NAD(P)H:quinone reductase gene
Favreau, L. V., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64358-7 · Cited by 497
Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism
Tong, K. I., Kobayashi, A., Katsuoka, F., & Yamamoto, M. (2006) · Biological Chemistry · doi:10.1515/bc.2006.164 · Cited by 473
Tumours with PI3K activation are resistant to dietary restriction
Kalaany, N. Y., & Sabatini, D. M. (2009) · Nature · doi:10.1038/nature07782 · Cited by 468
Braun, S., Hanselmann, C., Gassmann, M. G., auf dem Keller, U., Born-Berclaz, C., Chan, K., Kan, Y. W., & Werner, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5492-5505.2002 · Cited by 410
WILLCOX, B. J., WILLCOX, D. C., TODORIKI, H., FUJIYOSHI, A., YANO, K., HE, Q., CURB, J. D., & SUZUKI, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.037 · Cited by 370 · cited 1×
“During this time, they showed the lowest incidence of coronary heart disease, stroke, cancer and delayed ageing in the world (Suzuki, 2001; Willcox et al., 2007).”
Li, Y., & Jaiswal, A. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42151-5 · Cited by 353
Kiritoshi, S., Nishikawa, T., Sonoda, K., Kukidome, D., Senokuchi, T., Matsuo, T., Matsumura, T., Tokunaga, H., Brownlee, M., & Araki, E. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2570 · Cited by 345
Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells
Chen, X.-L., Varner, S. E., Rao, A. S., Grey, J. Y., Thomas, S., Cook, C. K., Wasserman, M. A., Medford, R. M., Jaiswal, A. K., & Kunsch, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203161200 · Cited by 333
Lee, J.-M., Shih, A. Y., Murphy, T. H., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305204200 · Cited by 308 · cited 2×
“…enzymes are essential for neuronal survival because they block neurotoxicity derived from glutathione depletion, lipid peroxidation, intracellular calcium overload, excitotoxins and disruption of the mitochondrial Oncogene electron transport chain (Shih et al., 2003; Lee et al., 2003a, 2005a).”
Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust
Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., & Yamamoto, M. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9176 · Cited by 297
Pietsch, E. C., Chan, J. Y., Torti, F. M., & Torti, S. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210664200 · Cited by 284
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273 · cited 1×
“Genetic ablation of the NRF2 gene increases the size of the lesions, whereas transplantation of NRF2-overexpressing astrocytes reduces it (Calkins et al., 2005; Shih et al., 2005).”
Hyun, D.-H., Emerson, S. S., Jo, D.-G., Mattson, M. P., & de Cabo, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608008103 · Cited by 267 · cited 1×
“Previous work carried out in our laboratory has shown that cytochrome b5 reductase and NQO1 expression and activities are increased in plasma membranes from rodent’s tissues under long-term CR (Manjgaladze et al., 1993; De Cabo et al., 2004; Hyun et al., 2006, 2007).”
Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Williams, K. V., Mullen, M. L., Kelley, D. E., & Wing, R. R. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.2 · Cited by 194
Muto, A., Hoshino, H., Madisen, L., Yanai, N., Obinata, M., Karasuyama, H., Hayashi, N., Nakauchi, H., Yamamoto, M., Groudine, M., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5734 · Cited by 190 · cited 1×
“…well as two distantly related proteins termed Bach1 and Bach2 (Chan et al., 1993a, 1993b; Moi et al., 1994; Itoh et al., 1995; Oyake et al., 1996; Muto et al., 1998; Kobayashi Received 16 July 2010; revised 8 September 2010; accepted 18 September 2010; published online 8 November 2010…”
Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon, G. B., Shantz, L. M., & Talalay, P. (1987) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(87)90023-9 · Cited by 159 · cited 1×
“It has been shown that dehydroepiandrosterone inhibits glucose-6-phosphate dehydrogenase, leading to a lower NADPH and ribose 5-phosphate levels with a consequent inhibition of deoxyribonucleotide synthesis (Gordon et al., 1987; Garcea et al., 1988; Shantz et al., 1989; Pashko et al., 1991).”
Guo, Z., Mitchell-Raymundo, F., Yang, H., Ikeno, Y., Nelson, J., Diaz, V., Richardson, A., & Reddick, R. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00008-8 · Cited by 121
Complexity of CNC Transcription Factors As Revealed by Gene Targeting of the Nrf3 Locus
Derjuga, A., Gourley, T. S., Holm, T. M., Heng, H. H. Q., Shivdasani, R. A., Ahmed, R., Andrews, N. C., & Blank, V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3286-3294.2004 · Cited by 100
Nrf2 activity is lost in the spinal cord and its astrocytes of aged mice
Duan, W., Zhang, R., Guo, Y., Jiang, Y., Huang, Y., Jiang, H., & Li, C. (2009) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-009-9194-5 · Cited by 75 · cited 1×
“NRF2 expression has shown an age-related decrease in rodent and human tissues (Suh et al., 2004; Shih and Yen, 2007; Collins et al., 2009; Duan et al., 2009), possibly leading to higher levels of ROS and increased risk of cancer.”
Cited by
Metformin improves healthspan and lifespan in mice
Martin-Montalvo, A., Mercken, E. M., Mitchell, S. J., Palacios, H. H., Mote, P. L., Scheibye-Knudsen, M., Gomes, A. P., Ward, T. M., Minor, R. K., Blouin, M.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3192 · Cited by 1,445
Promoting Health and Longevity through Diet: From Model Organisms to Humans
Fontana, L., & Partridge, L. (2015) · Cell · doi:10.1016/j.cell.2015.02.020 · Cited by 1,245
“2013), HSF and NRF2 (Akerfelt et al., 2010; Martín-Montalvo et al., 2011).”
InfluentialMelatonin: an ancient molecule that makes oxygen metabolically tolerable
Manchester, L. C., Coto‐Montes, A., Boga, J. A., Andersen, L. P. H., Zhou, Z., Galano, A., Vriend, J., Tan, D., & Reiter, R. J. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12267 · Cited by 945
Senescence and aging: the critical roles of p53
Rufini, A., Tucci, P., Celardo, I., & Melino, G. (2013) · Oncogene · doi:10.1038/onc.2012.640 · Cited by 798
Allostery in Disease and in Drug Discovery
Nussinov, R., & Tsai, C.-J. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 761
Metadata
- Authors
- Martín-Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R.
- Venue
- Oncogene
- Published
- 2010-11-08
- Volume
- 30
- Issue
- 5
- Pages
- 505-520
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2051808967
- Cited by
- 129
- References
- 50
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.